The ECTRIMS 2022 – 38th Congress of the European Committee for Treatment and Research of Multiple Sclerosis, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 18 European...
Read MoreThis year at ECTRIMS you can go on a “date” with someone with the same research interests as you. Introducing Braindate, a service ECTRIMS is using to make it easy for attendees seeking expertise on key MS topics to...
Read MoreThe ECTRIMS 2022 – 38th Congress of the European Committee for Treatment and Research of Multiple Sclerosis, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 18 European...
Read MorePlanning committees developed an interesting and diverse scientific program. Well-known session formats such as Scientific Sessions, Hot Topics or Meet the Experts are being brought back again this year The schedule also offers...
Read More
Changes in cholesterol metabolism may be linked to the progression of multiple sclerosis (MS)...
Read More
Active primary progressive multiple sclerosis (PPMS) has effective treatment options, thus...
Read More
All multiple sclerosis (MS) patients should have the COVID-19 vaccine, as suggested by the...
Read More
For patients with relapsing-remitting multiple sclerosis (MS), teriflunomide (TF) is a...
Read More
Patients still face an increased risk of debilitating rebound illness within 6 months of drug...
Read More
Recently, 3 innovative, safe, and effective biologic medicines for neuromyelitis optica spectrum...
Read More
Appropriate use of the anti-CD19 B-cell depleting antibody inebilizumab (INEB) in the treatment of...
Read More
Health-related toughness is a personality trait that has the potential to mitigate the...
Read More
Demyelinating disease that primarily affects the spinal cord and optic nerve, neuromyelitis optica...
Read More
Immunosuppressive treatment is a major cause for worry for patients with neuromyelitis optica...
Read More
The primary forum for people and medical experts to share their firsthand knowledge of medical...
Read More
There was strong proof that a diet low in fermentable oligo-, di-, monosaccharides, and polyols...
Read More
For patients with newly diagnosed, IDH1-mutated acute myeloid leukemia (AML), ivosidenib (IVO)...
Read More
In patients with hematologic malignancies, the use of Orca-T, a high-precision cell therapy, led...
Read More
Tenapanor is a first-in-class, poorly absorbed, small-molecule inhibitor of the intestinal...
Read More
Tenapanor is a small-molecule inhibitor of the intestinal sodium/hydrogen exchanger 3 (NHE3) that...
Read More
